LILAK
Price
$5.87
Change
+$0.13 (+2.26%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.44B
37 days until earnings call
RNA
Price
$29.17
Change
-$0.15 (-0.51%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
3.53B
50 days until earnings call
Interact to see
Advertisement

LILAK vs RNA

Header iconLILAK vs RNA Comparison
Open Charts LILAK vs RNABanner chart's image
Liberty Latin America
Price$5.87
Change+$0.13 (+2.26%)
Volume$12.55K
Capitalization1.44B
Avidity Biosciences
Price$29.17
Change-$0.15 (-0.51%)
Volume$20.08K
Capitalization3.53B
LILAK vs RNA Comparison Chart in %
Loading...
LILAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LILAK vs. RNA commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LILAK is a Hold and RNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (LILAK: $5.74 vs. RNA: $29.32)
Brand notoriety: LILAK and RNA are both not notable
LILAK represents the Wireless Telecommunications, while RNA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: LILAK: 204% vs. RNA: 107%
Market capitalization -- LILAK: $1.44B vs. RNA: $3.53B
LILAK [@Wireless Telecommunications] is valued at $1.44B. RNA’s [@Biotechnology] market capitalization is $3.53B. The market cap for tickers in the [@Wireless Telecommunications] industry ranges from $12.88T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Wireless Telecommunications] industry is $17.66B. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LILAK’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • LILAK’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, LILAK is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LILAK’s TA Score shows that 6 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • LILAK’s TA Score: 6 bullish, 3 bearish.
  • RNA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LILAK is a better buy in the short-term than RNA.

Price Growth

LILAK (@Wireless Telecommunications) experienced а +7.09% price change this week, while RNA (@Biotechnology) price change was -6.53% for the same time period.

The average weekly price growth across all stocks in the @Wireless Telecommunications industry was -0.19%. For the same industry, the average monthly price growth was +0.67%, and the average quarterly price growth was +47.32%.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.37%. For the same industry, the average monthly price growth was +28.11%, and the average quarterly price growth was +12.64%.

Reported Earning Dates

LILAK is expected to report earnings on Jul 30, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Wireless Telecommunications (-0.19% weekly)

Wireless Telecom includes companies that sell wireless antenna or satellite-based communication services. This is the fastest-growing area in communications, as more and more communication and computing happen on mobile devices and cloud-based platforms. Wireless telecom is a key industry for global connectivity, and has even further room for growth in emerging markets and in rural parts of developed nations. People’s growing need for speed in data connectivity, higher resolution, and smoother video streaming and multimedia applications should drive growth and competition within this segment. T-Mobile US, Inc., Vodafone Group, and Sprint Corporation are some major providers of wireless telecom.

@Biotechnology (-2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.53B) has a higher market cap than LILAK($1.44B). RNA YTD gains are higher at: 0.825 vs. LILAK (-9.464). LILAK has higher annual earnings (EBITDA): 1.55B vs. RNA (-430.35M). RNA has more cash in the bank: 1.38B vs. LILAK (989M). RNA has less debt than LILAK: RNA (5.97M) vs LILAK (8.26B). LILAK has higher revenues than RNA: LILAK (4.51B) vs RNA (8.93M).
LILAKRNALILAK / RNA
Capitalization1.44B3.53B41%
EBITDA1.55B-430.35M-360%
Gain YTD-9.4640.825-1,147%
P/E Ratio8.30N/A-
Revenue4.51B8.93M50,532%
Total Cash989M1.38B72%
Total Debt8.26B5.97M138,333%
FUNDAMENTALS RATINGS
LILAK: Fundamental Ratings
LILAK
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LILAKRNA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
74%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LILAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSMR23.430.01
+0.03%
Invesco BulletShares 2027 Muncpl Bd ETF
CMU3.36-0.01
-0.15%
MFS High Yield Municipal Trust
PMAY37.15-0.06
-0.16%
Innovator U.S. Equity Power BffrETF™-May
QTEC202.63-1.56
-0.76%
First Trust NASDAQ-100-Tech Sector ETF
DXYZ37.00-2.38
-6.04%
Destiny Tech100

LILAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, LILAK has been closely correlated with LILA. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if LILAK jumps, then LILA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LILAK
1D Price
Change %
LILAK100%
+3.61%
LILA - LILAK
99%
Closely correlated
N/A
SHEN - LILAK
45%
Loosely correlated
-1.70%
S - LILAK
39%
Loosely correlated
-1.36%
CCOI - LILAK
37%
Loosely correlated
+0.64%
CMCSA - LILAK
35%
Loosely correlated
+0.79%
More